69 related articles for article (PubMed ID: 3089989)
1. High level of beta-type transforming growth factor activity in human urine obtained from cancer patients.
Nishimura R; Okumura H; Noda K; Yasumitsu H; Umeda M
Jpn J Cancer Res; 1986 Jun; 77(6):560-7. PubMed ID: 3089989
[TBL] [Abstract][Full Text] [Related]
2. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer.
Sherwin SA; Twardzik DR; Bohn WH; Cockley KD; Todaro GJ
Cancer Res; 1983 Jan; 43(1):403-7. PubMed ID: 6600160
[TBL] [Abstract][Full Text] [Related]
3. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
Stromberg K; Hudgins WR
Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
[TBL] [Abstract][Full Text] [Related]
4. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor beta as a potent promoter in two-stage BALB/c 3T3 cell transformation.
Hamel E; Katoh F; Mueller G; Birchmeier W; Yamasaki H
Cancer Res; 1988 May; 48(10):2832-6. PubMed ID: 3258789
[TBL] [Abstract][Full Text] [Related]
6. Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors.
Hudgins WR; Orth DN; Stromberg K
Cancer Res; 1988 Mar; 48(6):1428-34. PubMed ID: 3257897
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
[TBL] [Abstract][Full Text] [Related]
8. Separation of transforming growth factors TGF alpha and TGF beta during chromatographic purification of extracts from mouse C-234 tumors.
Popik W
Arch Immunol Ther Exp (Warsz); 1987; 35(6):839-51. PubMed ID: 3508041
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin-associated transforming growth factor.
Fava RA; McClure DB
J Cell Physiol; 1987 May; 131(2):184-9. PubMed ID: 3495542
[TBL] [Abstract][Full Text] [Related]
10. Comparison of urinary transforming growth factor-alpha in women with disseminated breast cancer and healthy control women.
Stromberg K; Duffy M; Fritsch C; Hudgins WR; Sharp ES; Murphy LD; Lippman ME; Bates SE
Cancer Detect Prev; 1991; 15(4):277-83. PubMed ID: 1794134
[TBL] [Abstract][Full Text] [Related]
11. High molecular weight transforming growth factor beta is excreted in the urine in active nodular sclerosing Hodgkin's disease.
Newcom SR; Tagra KK
Cancer Res; 1992 Dec; 52(24):6768-73. PubMed ID: 1458464
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor activity in pleural and peritoneal effusions from cancer and non-cancer patients.
Sairenji M; Suzuki K; Murakami K; Motohashi H; Okamoto T; Umeda M
Jpn J Cancer Res; 1987 Aug; 78(8):814-8. PubMed ID: 3115927
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intra- and extracellular transforming growth factors from nontransformed and chemically transformed mouse embryo cells.
Tucker RF; Volkenant ME; Branum EL; Moses HL
Cancer Res; 1983 Apr; 43(4):1581-6. PubMed ID: 6299525
[TBL] [Abstract][Full Text] [Related]
14. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactive alpha transforming growth factor activity in effusions from cancer patients as a marker of tumor burden and patient prognosis.
Arteaga CL; Hanauske AR; Clark GM; Osborne CK; Hazarika P; Pardue RL; Tio F; Von Hoff DD
Cancer Res; 1988 Sep; 48(17):5023-8. PubMed ID: 3165707
[TBL] [Abstract][Full Text] [Related]
16. Comparison of growth factors functionally related to epidermal growth factor in the urine of normal and human tumor-bearing athymic mice.
Twardzik DR; Kimball ES; Sherwin SA; Ranchalis JE; Todaro GJ
Cancer Res; 1985 May; 45(5):1934-9. PubMed ID: 3872712
[TBL] [Abstract][Full Text] [Related]
17. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M
J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factors in solid human malignant neoplasms.
Nickell KA; Halper J; Moses HL
Cancer Res; 1983 May; 43(5):1966-71. PubMed ID: 6299535
[TBL] [Abstract][Full Text] [Related]
19. Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor.
Stromberg K; Hudgins WR; Dorman LS; Henderson LE; Sowder RC; Sherrell BJ; Mount CD; Orth DN
Cancer Res; 1987 Feb; 47(4):1190-6. PubMed ID: 3026622
[TBL] [Abstract][Full Text] [Related]
20. Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F.
Pircher R; Lawrence DA; Jullien P
Cancer Res; 1984 Dec; 44(12 Pt 1):5538-43. PubMed ID: 6093998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
